Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Complete Hydatidiform Mole With Coexisting Live Fetus: Outcomes After Assisted Reproductive Technology and Natural Conception-Two Case Reports.

Created on 29 Jul 2026

Authors

Mert Eyupoglu, Erdem Fadiloglu, Muhammed Onur Atakul, Diclehan Orhan, Ozgur Deren, Murat Cagan

Published in

The journal of obstetrics and gynaecology research. Volume 52. Issue 8. Pages e70424.

Abstract

Complete hydatidiform mole with a coexisting live fetus in a twin pregnancy is exceptionally rare and carries major maternal and fetal risks. We describe two such pregnancies to illustrate management options. The first followed frozen-thawed single blastocyst transfer and presented at 13 weeks with a live fetus, a separate molar mass, an intramural fibroid, markedly elevated serum beta-human chorionic gonadotropin, and biochemical hyperthyroidism. Multidisciplinary assessment led to hysterotomy with removal of the fetus, molar tissue, and fibroids, followed by rapid recovery and no gestational trophoblastic neoplasia. The second was a spontaneously conceived twin pregnancy with a live 9-week fetus and multicystic molar tissue that was evacuated by suction curettage. An initial decline in beta-human chorionic gonadotropin was followed by a low-level plateau that resolved after a single low-dose methotrexate cycle. These cases highlight the need for individualized, multidisciplinary care and close biochemical follow-up.

PMID:
42521630
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement